Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study

British Medical Journal

Volumn 312, Issue 7030, 1996, Pages 537-539

  Lehtinen, Matti ^a,j   Dillner, Joakim ^b   Knekt, Paul ^c   Luostarinen, Tapio ^d   Aromaa, Arpo ^c   Kirnbauer, Reinhard ^e   Koskela, Pentti ^a   Paavonen, Jorma ^f   Peto, Richard ^g   Schiller, John T ^h   Hakama, Matti ⁱ  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d FINNISH CANCER REGISTRY   (Finland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF TAMPERE   (Finland)

^j Department of Chronic Viral Diseases   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SMOKING; UTERINE CERVIX CARCINOMA; VIRUS INFECTION;

EID: 0030044035     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7030.537     Document Type: Article

References (14)

1. zurHausen H. Viruses in human cancers. Science 1991;254:1167-72.
2. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85: 953-64.
3. Hakama M, Lehtinen M, Knekt P, Aromaa A, Leinikki P, Miettinen A, et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol 1993;137:166-70.
4. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-8.
5. Dillner J, Wiklund F, Lenner P, Eklund C, Fredriksson-Shanazarian V, Schiller JT, et al. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int J Cancer 1995;60:377-82.
6. Dillner J, Lenner P, Lehtinen M, Eklund C, Heino P, Wiklund F, et al. A population based seroepidemiological study of cervical cancer. Cancer Res 1994;54:134-41.
7. Lehtinen M, Rantala I, Aine R, Miettinen A, Teisala K, Heinonen PK, et al. B-cell response in chlamydial endometritis. Eur J Clin Microbiol Infect Dis 1986;5:596-8.
8. Hanna L, Keshismyan H. Chlamydial antigens stabilized with formalin for use in the micro-immunofluorescence test. J Clin Microbiol 1980;12:409.
9. Mårdh PA, Puolakkainen M, Paavonen J. Chlamydia. New York: Plenum, 1989:1-326.
10. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyons: International Agency for Research on Cancer, 1980. (IARC Scientific Publications No 32.)
11. Mehta CP, Patel NR, Gray R. Computing exact confidence intervals for the common odds ratio in several 2x2 contingency tables. J Am Stat Assoc 1985;80:969-73.
12. Paavonen J, Kiviat N. Cervical neoplasia. In: Holmes KK, Márdh PA, Sparling PF, Wiesmer PJ, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill.
13. Nommenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Munoz N, Bosch FX, et al. Serological response to human papillomavirus type 16 virus-like particles in HPV16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995;172:19-24.
14. Chabaud M, Munoz N, Cottu C, Coursaget P, Anthonioz P, Day N, et al. Human papillomavirus infection in women with cervical cancer but without cytological abnormalities in the preceding years. In: Stanley MA, ed. Immunology of human papillomaviruses (HPVS). New York: Plenum, 1994: 59-62.